Hillman Capital Management Inc
Managed by Mark Hillman. $158.9M disclosed long-equity portfolio across 52 positions.
| # | Stock | Value | % of Portfolio |
|---|---|---|---|
| 1 | WARNER BROS DISCOVERY INC | $6.2M | 3.89% |
| 2 | ASML HOLDING N V | $5.9M | 3.71% |
| 3 | LAUDER ESTEE COS INC | $5.7M | 3.61% |
| 4 | CVS HEALTH CORP | $5.7M | 3.58% |
| 5 | GSK PLC | $5.6M | 3.53% |
| 6 | BOEING CO | $5.5M | 3.47% |
| 7 | BIOGEN INC | $5.4M | 3.38% |
| 8 | DUPONT DE NEMOURS INC | $5.4M | 3.37% |
| 9 | ANHEUSER BUSCH INBEV SA/NV | $5.3M | 3.33% |
| 10 | INTERNATIONAL FLAVORS&FRAGRA | $5.1M | 3.22% |
| 11 | MICROSOFT CORP | $5.1M | 3.22% |
| 12 | SPDR S&P 500 ETF TR | $4.6M | 2.86% |
| 13 | PFIZER INC | $4.4M | 2.75% |
| 14 | NIKE INC | $4.3M | 2.73% |
| 15 | CARMAX INC | $4.3M | 2.70% |
| 16 | KRAFT HEINZ CO | $4.3M | 2.70% |
| 17 | ZIMMER BIOMET HOLDINGS INC | $4.1M | 2.60% |
| 18 | BAXTER INTL INC | $4.0M | 2.54% |
| 19 | THE CAMPBELLS COMPANY | $3.9M | 2.47% |
| 20 | BROWN FORMAN CORP | $3.9M | 2.43% |
| 21 | ISHARES TR | $3.7M | 2.31% |
| 22 | BRISTOL-MYERS SQUIBB CO | $2.9M | 1.83% |
| 23 | TAIWAN SEMICONDUCTOR MFG LTD | $2.9M | 1.81% |
| 24 | US BANCORP DEL | $2.8M | 1.79% |
| 25 | AKAMAI TECHNOLOGIES INC | $2.8M | 1.76% |
For full quarterly history, transactions, and the investor profile, see Mark Hillman's page →
More related to Mark Hillman 0001314620
Compare with other superinvestors
Other superinvestors
By investing strategy
Hillman Capital Management Inc — overview
Mark Hillman runs Hillman Capital Management Inc, a multi-strategy investment firm tracked here via SEC 13F filings. As of the Q4 2025 13F filing, the disclosed long-equity portfolio is valued at $159M across 52 positions. The largest holdings are WARNER BROS DISCOVERY INC, ASML HOLDING N V, and LAUDER ESTEE COS INC (WARNER BROS DISCOVERY INC alone is 3.9% of the book).
Key takeaways
- Disclosed Q4 2025 portfolio: $159M.
- Top holdings: WARNER BROS DISCOVERY INC, ASML HOLDING N V, and LAUDER ESTEE COS INC.